Alex Delaney-Gesing

Articles

FDA accepts Genentech's BLA for PDS with ranibizumab to treat wet AMD

June 25, 2021

Article

If approved, PDS ranibizumab would become the first and only eye implant with continuous drug delivery, offering an alternative to more frequent anti-VEGF injections for people with wet AMD.

MeiraGTx reports Fast Track designation by FDA for gene therapy candidate to treat ACHM

January 26, 2021

Article

The FDA has granted Fast Track designation to MeiraGTx's AAV-CNGA3 gene therapy product candidate for the treatment of achromatopsia (ACHM).

What keeps ophthalmologists up at night (Part III)

January 20, 2021

Video

From patient care and treating glaucoma to the ongoing pandemic, ophthalmologists share the most pressing thoughts of concern leaving them awake at night.

Amydis announces successful pre-IND meeting with FDA to develop retinal tracer for amyloid angiopathy diagnosis

January 11, 2021

Article

Amydis announced the successful completion of a pre-investigational new drug (IND) meeting with the FDA for its candidate AMDX-2011P, a small-molecule retinal tracer that targets amyloid beta to diagnosis amyloid angiopathy.